Pegylated interferon alfa-2b

BIOLOGICAL9 trials

Conditions

Chronic Hepatitis CChronic Hepatitis C (CHC)Chronic Myelogenous LeukemiaEssential ThrombocytopeniaHepatitis CHepatitis C, ChronicMelanoma

Phase 2

A Study of Different Doses of Grazoprevir (MK-5172) Given With Pegylated Interferon Alfa-2b and Ribavirin to Treatment-Naïve Participants With Chronic Hepatitis C (MK-5172-038)

CompletedNCT01710501

Merck Sharp & Dohme LLCChronic Hepatitis C (CHC)

Start: 2012-12-07End: 2014-01-29Updated: 2021-02-04

A Phase II Study of Pegylated Interferon Alfa-2b for the Adjuvant Treatment of Melanoma Subjects in Russia (MK-4031-400)

CompletedNCT02155322

Merck Sharp & Dohme LLCMelanoma

Start: 2014-08-19End: 2016-03-21Updated: 2018-08-23

Polyethylene Glycol Interferon Alfa-2b (PEG Intron) Versus Interferon Alfa-2b (INTRON^® A) in the Treatment of Newly Diagnosed Chronic Myelogenous Leukemia (CML) (C98026)

TerminatedNCT03547154

Merck Sharp & Dohme LLCChronic Myelogenous Leukemia

Start: 1998-10-22End: 2001-02-20Updated: 2019-08-12

Pegylated Interferon Alfa-2b Versus Interferon Alfa Therapy in Childhood and Adolescent Essential Thrombocythemia

RecruitingNCT04226950

Institute of Hematology & Blood Diseases Hospital, ChinaEssential Thrombocytopenia

Start: 2020-01-10End: 2024-11-20Target: 40Updated: 2024-07-03

Pegylated Interferon Alfa-2b Versus Interferon Alfa Therapy in Adult Essential Thrombocythemia

NCT05395507

Institute of Hematology & Blood Diseases Hospital, ChinaEssential Thrombocytopenia

Start: 2022-06-01End: 2025-06-30Target: 194Updated: 2024-07-03

Phase 3

Study of Viramidine to Ribavirin in Patients With Chronic Hepatitis C Who Are Treatment-Naive

CompletedNCT00230958

Bausch Health Americas, Inc.Chronic Hepatitis C

Start: 2003-12-31End: 2006-01-31Target: 900Updated: 2012-06-22

Evaluation of Peginterferon Alfa-2b Monotherapy and Combination With Ribavirin in Participants With Acute Hepatitis C (P03552/MK-4031-137)

CompletedNCT00686517

Merck Sharp & Dohme LLCHepatitis C

Start: 2003-12-31End: 2010-12-31Updated: 2017-04-05

Phase 4

Pegylated Interferon (PEG-IFN) Alfa-2b and Low Dose Ribavirin for the Treatment of Chronic Hepatitis C Patients With Genotype 1 High Viral Load and Low Body Weight (Study P05172)(COMPLETED)

CompletedNCT00686777

Merck Sharp & Dohme LLCHepatitis C, Chronic

Start: 2008-01-31End: 2010-12-31Updated: 2017-04-07

The SIM-SOF Trial for Hepatitis C

CompletedNCT02168361

Center For Hepatitis C, Atlanta, GAChronic Hepatitis C

Start: 2013-12-31End: 2015-04-30Updated: 2016-03-14

Related Papers

Grazoprevir plus peginterferon and ribavirin in treatment‐naive patients with hepatitis C virus genotype 1 infection: a randomized trial

Journal of Viral Hepatitis2015-09-1015 citations

The combination of simeprevir and sofosbuvir is more effective than that of peginterferon, ribavirin, and sofosbuvir for patients with hepatitis C-related Child's class A cirrhosis.